Copyright of ImmunoBase

Copyright © 2017 ImmunoBase. All rights reserved.

ImmunoBase comprises a series of electronic documents and information processing software, the reference copy of which currently resides at the Internet address http://www.immunobase.org.

This publication is distributed under terms of the GNU General Public License (GPL) at no charge. The GNU GPL is an open source license, as that term is used by the Open Source Initiative. We urge you to consult the full text of the GNU General Public License (GPL) for the full list of rights granted to you therein.

All publicly visible data in ImmunoBase is open access by which we mean it is covered by the GNU GPL. It is our policy to place all publicly visible data on out FTP site in a form that is easy for others to download.

Unpublished data submitted to ImmunoBase will be kept confidential until the submitter gives permission for the data to be made public or upon publication. Until such data is made public, it will only be available to ImmunoBase staff who require access to prepare the data for inclusion in the database and eventual release to the public. Neither the data nor any information about the data (including its existence) will be revealed to anyone who may gain scientific advantage from early access to this information. We recognize that individuals and groups based in the same institutions as ImmunoBase or collaborating with ImmunoBase personnel are likely to be scientific competitors of some data submitters. Special care will be taken in such cases to avoid even the appearance of improper information access.

Standard technical means will be employed to prevent access to private data by unauthorized individuals, including the use of encrypted logins to control access to private data.

Warranty

ImmunoBase, its contributors and Juvenile Diabetes Research Foundation and Wellcome Trust make no warranty of any kind with respect to the subject matter included herein. ImmunoBase, its contributors and Juvenile Diabetes Research Foundation and Wellcome Trust specifically disclaim all warranties, expressed, implied or otherwise, including without limitation, all warranties of merchantability, fitness for a particular purpose, or non-infringement.

The information contained in this publication is subject to change without notice.

By viewing or using this information the user agrees that in no event shall ImmunoBase, its contributors or Juvenile Diabetes Research Foundation and Wellcome Trust be liable for any special, incidental, indirect, or consequential damages of any kind, or any damages whatsoever, whether or not advised of the possibility of damage, arising out of or in connection with the use or performance of this information.

Disclaimer

Information in ImmunoBase is curated from the scientific literature, including unrefereed sources such as abstracts, reviews, and personal communications. Statements of fact are not vetted by ImmunoBase. Users should remember that published information is not always correct information and are encouraged to use ImmunoBase as a guide to the literature rather than as a substitute for it.

Data Access Agreement

This Data Access Agreement governs the terms of access to the Data generated or collated by ImmunoBase.

Background

The Member who contributed the Data (“Data Producer”) together with their Collaborators, are the custodians of that Data and hold such ownership rights as may exist in relation to such Data. The Members are committed to providing access for the Research Community (by way of the ImmunoBase Database) for Biomedical Research purposes.

The Recipient and the Recipient Institution agree to be bound by the terms and conditions contained herein,and agree to ensure that all Data Users comply with the terms and conditions of this Agreement.

For the sake of clarity, the terms of access set out in this Data Access Agreement apply both to the Recipient and the Recipient Institution.

Terms and Conditions

  1. The Recipient and the Recipient Institution agree to only use the Data for academic research.
  2. The Recipient and the Recipient Institution agree to preserve, at all times, the confidentiality of the Data. In particular, they undertake not to use, or attempt to use, the Data to compromise or otherwise infringe the confidentiality of information on the Donors.
  3. The Recipient and the Recipient Institution agree to protect the confidentiality of Donors in any Publications that they prepare by taking all reasonable care to limit the possibility of Donor identification.
  4. The Recipient and the Recipient Institution agree not to link or combine the Data provided under this Data Access Agreement to other information or other data available to them in a way that could identify the Donors, even if access to that data has been formally granted to the Recipient and the Recipient Institution, or is freely available without restriction.
  5. The Recipient and the Recipient Institution agree not to transfer or disclose the Data, in whole or part or any copies thereof, in whole or part (in any medium), to anyone not listed as:
    1. a Data User in Schedule VI of this Data Access Agreement;
    2. a Co-Applicant on the Research Project who’s institution has signed as Recipient Institution in a parallel Data Access Agreement for this Research Project; or
    3. a Co-Applicant’s Data User as listed in Schedule VI of the parallel Data Access Agreement for this Research Project, except as necessary for data safety monitoring, national audits or as required by law. Should the Recipient or the Recipient Institution wish to share the Data with an Third Party that is not a Co-Applicant, that Third Party must complete the Data Access Application for External Investigators prior to receiving the Data.
  6. Pursuant to the warranty secured from the Data Producer under the Data Deposit Agreement, ImmunoBase hereby warrants that the Data has been obtained in accordance with all relevant laws and guidelines and that the Data has been obtained from Donors that have given their informed consent for their tissue samples and Data to be used for research purposes.
  7. Subject to Clause 6 above, the Recipient and the Recipient Institution agree that ImmunoBase, the Data Producer(s) or Collaborator involved in the creation, funding or protection of the Data:
    1. Make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of the Data;
    2. Exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit) and any associated costs made against the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of the Data or from the unavailability of, or break in access to, the Data for whatever reason and; and
    3. Bear no responsibility for the further analysis or interpretation of these Data.
  8. The Recipient and the Recipient Institution agree to follow the Fort Lauderdale Guidelines included as Schedule I of this Agreement and the Toronto Statement included as Schedule II of this Data Access Agreement. This includes but is not limited to: recognising the contribution of the Data Producer and their Collaborators in the Primary Publication describing and analysing the Data (as appropriate); the version of the Data; the role of ImmunoBase; and the role of any Collaborators or funders of the Data collection or Cleaning, as specified in the Data Deposit Application or otherwise disclosed by the Data Access Committee, in all Publications arising from the Research Project in whole or in part. An example of suitable wording is provided in the Publications Policy attached as Schedule III of this Agreement.
  9. The Recipient and the Recipient Institution agree to follow the Publication Policy attached as Schedule III of this Agreement. This includes respecting the Publication Moratorium period for Data Producers and their Collaborators to publish the first peer-review report(s) describing and analysing the Data.
  10. The Recipient and Recipient Institution understand and acknowledge that the Data are protected by copyright and other intellectual property rights, and that duplication, except as reasonably required to carry out the Research Project, or sale of all or part of the Data on any media is not permitted.
  11. The Recipient and the Recipient Institution agree not to make intellectual property claims on the Data nor use the Data to make a related intellectual property claim,and not to use or encumber the results of the Research Project in a manner that would prevent or block access to, or use of, any element of the Data, or conclusions drawn directly from the Data.
  12. The Recipient and the Recipient Institution recognise that nothing in this Data Access Agreement shall operate to transfer to the Recipient or Recipient Institution any intellectual property rights relating to the Data. Subject to Clause 11, the Recipient and the Recipient Institution can elect to perform further research with the results of the Research Project that would add intellectual and resource capital to the Data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the Recipient and the Recipient Institution agree to implement licensing policies that will not obstruct further research with the Data and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006). These two policies (NIH and OECD) are included as Schedule IV and V of this Agreement.
  13. The Data was contributed by the Members with the objective of improving health. If results arising from the Recipient and the Recipient Institution use of the Data could provide health solutions for the benefit of people in the developing world, the Recipient and the Recipient Institution agree to offer non-exclusive licenses to use such results to low income and low-middle income countries (as defined by the World Bank) promptly on request. Such licenses shall be granted on a reasonable basis, which in the event of a request for research use shall be full paid up,revenue-free and otherwise without cost to the requesting party.
  14. Upon conclusion of the Research Project, the Recipient and the Recipient Institution hereby agree to destroy/discard the Data held unless obligated to retain the Data for archival purposes in conformity with applicable law.
  15. The Recipient and the Recipient Institution will ensure that the list of Data Users in Schedule VI is maintained and kept up-to-date and forward an updated copy of this Schedule, signed by an authorised official of the Recipient Institution to Data Access Committee to reflect any changes or departures in researchers, collaborators and personnel within 30 days of the changes made. Pending confirmation of receipt of the update list of Data Users from the Data Access Committee, any individual not listed as a Data User may not use the Data.
  16. The Recipient and the Recipient Institution must notify the Data Access Committee prior to making any significant change(s) to the Research Project. ImmunoBase will notify the Data Producer of any request to change the Research Project and shall liaise with the Data Producer in making a decision on the requested amendment.
  17. The Recipient and the Recipient Institution will notify the Data Access Committee as soon as they become aware of a breach of the terms or conditions of this Data Access Agreement.
  18. ImmunoBase reserves the right to terminate this Agreement immediately in the event of a breach by the Recipient, Data Users, or the Recipient Institution. Upon termination or otherwise upon conclusion of the Research Project, the Recipient and the Recipient Institution will be required to destroy any Data held, including copies and backup copies thereof unless obligated to retain the Data for archival purposes in conformity with applicable law.
  19. The Recipient and the Recipient Institution accept that it may be necessary for ImmunoBase or their appointed agent to alter the terms of this Data Access Agreement as required by a change in consent for the Data or another regulatory change which impacts on the scope of Data usage. In this event, ImmunoBase or their appointed agent will contact the Recipient and the Recipient Institution to inform them of any changes and the Recipient and Recipient Institution agree that their continued use of Data shall be dependent on the parties entering into a new version of this Data Access Agreement and use of the Data shall be suspended until execution.
  20. It is understood by the Recipient and the Recipient that Data: should only be accessible to named users (Data Users and the Recipient only); Data files should either have only user Unix read/write access, not group or world access, or project-specific Unix groups should be used for group access that contain only those names authorised to access the Data; User IDs within groups should be reviewed at 6 monthly intervals by the Recipient; Data kept on laptops should be encrypted when not in active use, either in individual encrypted files or in encrypted directories/partitions; and Data should not be held on USB keys or other portable hard drives. The Recipient Institution hereby represents that they have equivalent security measures in place and will store the Data in accordance with this clause. If requested, the Recipient and the Recipient Institution will allow data security and management documentation to be inspected to verify that they are complying with the terms of this Data Access Agreement.
  21. The Recipient Institution hereby agrees to submit a report to the Data Access Committee containing all data, results, and conclusions, if requested or otherwise promptly on completion of the Research Project. The Data Access Committee agrees to treat the report and all information, data, results, and conclusions contained therein as confidential information belonging to the Recipient Institution until the Recipient Institution has Published on the project.
  22. Further to the obligation set out in the recitals to this Data Access Agreement, the Recipient and the Recipient Institution agree to distribute a copy of this Data Access Agreement and explain its content to any person mentioned in Schedule VI. The Recipient Institution shall be liable for any breach of this Data Access Agreement by any Data User.
  23. This Agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.
THE TERMS OF THIS DOCUMENT ARE NON-NEGOTIABLE